Annual report pursuant to Section 13 and 15(d)

NOTES PAYABLE (Details Narrative)

v3.22.4
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jul. 28, 2020
Nov. 30, 2022
Nov. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Unamortized Discount       $ 2,954,390 $ 2,262,388
Interest Expense, Debt       3,097,000 $ 2,709,000
Lenders [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Unamortized Discount       $ 2,954,000  
K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt issuance cost $ 1,244,000        
Insurance Policy [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Prepaid Expense, Current   $ 418,750      
Loan Agreement [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Notes payable   452,250 $ 984,375    
Debt Instrument, Periodic Payment   $ 51,387 $ 111,041    
Monthly loan payments term   nine-month period nine-month period    
Debt Instrument, Interest Rate, Stated Percentage   5.40% 3.64%    
Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Interest Rate, Stated Percentage       12.75%  
Secured debt $ 50,000,000     $ 21,590,000  
Debt Instrument, Description The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months commencing on September 1, 2022.        
Debt Instrument, Maturity Date Aug. 01, 2024        
Debt Conversion, Converted Instrument, Amount       $ 5,000,000  
Debt Instrument, Convertible, Conversion Price       $ 282.00  
Warrants to purchase shares of common stock, exercised 2,874        
Exercise price of warrants $ 208.80        
Proceeds from Warrant Exercises $ 472,000        
Proceeds from prepayment and default features 546,000        
Final payment 1,590,000     $ 1,590,000  
Increase in fair value of conversion option       $ 573,000  
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Secured debt 20,000,000        
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-Based Payment Arrangement, Tranche Two [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Secured debt 20,000,000        
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-Based Payment Arrangement, Tranche Three [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Secured debt $ 10,000,000        
Event of Default - Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Interest Rate, Stated Percentage       5.00%  
Debt Instrument, Maturity Date       Aug. 01, 2024  
Amended loan agreement | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Description The Company entered into an Amendment to the Loan and Security Agreement (the "Amended Loan and Security Agreement") on October 25, 2022. The Amended Loan and Security Agreement defers the commencement of principal repayments by a one-year period from September 1, 2022 to September 1, 2023 and if the Company raises at least $30 million in net proceeds through capital raising transactions, the commencement of principal repayments will be deferred by an additional six months to March 1, 2024. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche.        
Debt issuance cost $ 119,000        
Debt 1 [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Conversion, Converted Instrument, Amount       $ 2,000,000  
Debt 1a [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Conversion, Converted Instrument, Amount       $ 875,000  
Debt 1a [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Convertible, Conversion Price       $ 4.50  
Debt 1a [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Convertible, Conversion Price       $ 282.00  
Debt 1b [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Conversion, Converted Instrument, Amount       $ 1,125,000  
Debt 1b [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Convertible, Conversion Price       $ 7.875  
Debt 1b [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Convertible, Conversion Price       $ 282.00  
Debt 2 [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Conversion, Converted Instrument, Amount       $ 3,000,000  
Debt Instrument, Convertible, Conversion Price       $ 282.00